Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

LianBio - American Depositary Shares (NQ: LIAN )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.3110 (5)
Ask (Size) 0.3399 (1)
Prev. Close 0.3190
Today's Range N/A - N/A
52wk Range 0.2712 - 4.990
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's Going On With LianBio (LIAN) Stock?
LianBio shares are trading higher by some 84% to $0.35 Friday afternoon on continued volatility. The company in late February announced its intent to delist its ADSs from the Nasdaq Global Market. 
Via Benzinga
Why Is LianBio (LIAN) Stock Moving Today?
LianBio stock is incredibly volatile on Friday as heavy trading rocks LIAN amid plans for a voluntary delisting of the shares. 
Via InvestorPlace

Performance

More News

Read More
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
LianBio Announces Voluntarily Delisting from Nasdaq
From LianBio
Via GlobeNewswire
B of A Securities Downgrades LianBio: Here's What You Need To Know
Via Benzinga
Week In Review: LianBio To Close Operations; Will Pay $528 Million To Shareholders
Via Talk Markets
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Ecolab Posts Strong Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
LianBio Announces Completion of Strategic Review
From LianBio
Via GlobeNewswire
Week In Review: $1.7 Billion Collaboration Between Elpiscience And Astellas Is Final 2023 Deal
Via Talk Markets
LianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian Markets
From LianBio
Via GlobeNewswire
LianBio Announces Departure of Chief Financial Officer
From LianBio
Via GlobeNewswire
LianBio Announces Departure of Chief Executive Officer
From LianBio
Via GlobeNewswire
LianBio’s Board of Directors Unanimously Determines not to Pursue Unsolicited Proposal from Concentra Biosciences
From LianBio
Via GlobeNewswire
Week In Review: Tang Capital Offers $465 Million For LianBio Plus 80% Of Any Licenses/Divestments
Via Talk Markets
LianBio Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
From LianBio
Via GlobeNewswire
LianBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
From LianBio
Via GlobeNewswire
LianBio Announces Topline Results from Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex Blepharitis
From LianBio
Via GlobeNewswire
ArcelorMittal, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Week In Review: Hansoh Sells Ex-China ADC Rights To GSK In $1.6 Billion Deal
Via Talk Markets
Why LianBio Stock Is Shooting Through the Roof This Week
Via The Motley Fool
LianBio Announces Presentation of Data from Phase 2a Study of Infigratinib in Patients with Gastric Cancer at ESMO Congress 2023
From LianBio
Via GlobeNewswire
Raymond James Maintains Outperform Rating for LianBio: Here's What You Need To Know
Via Benzinga
Nasdaq Gains 100 Points; Coca-Cola Earnings Top Expectations
Via Benzinga
Topics Stocks
Exposures US Equities
Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.